Skip to main content

Can Gut Candida Trigger Rheumatoid Arthritis? Maybe

Dr. Janet Pope | Abstract 2832 | ACR 2026 Orlando

Transcription

Hi, I'm Dr. Janet Pope. I'm a rheumatologist and professor of medicine at Western University, London, Canada. I tweet as Janet Burdau and I'm here as part of the RheumNow group covering the meeting ACR 2016 in sunny Orlando, Florida.

I wanted to talk about an oral presentation abstract number 2832 and I thought it was one of our best abstracts of today so far. So the idea is we know the microbiome is perturbed in just about any autoimmune disease — probably almost any disease — by treatment, by inflammation, by other things that might increase the chance of getting a disease. So the question here was could Candida albicans trigger rheumatoid arthritis, and this was out of the Denver group and they have the early RA cohort. They also have the RA at-risk patients and they were able to do all that kind of look as well as looking in a mouse model.

So first of all, Candida albicans can be increased in the microbiome of patients with RA and at-risk RA and this group showed it. Also we know in the gut that IgA for Candida albicans and some other Candida can be increased in these patients. So sort of a link that something's going on compared to controls.

Also, if they looked at a mouse model and they gave Candida to change the gut microbiome, it in and of itself was insufficient to cause inflammatory arthritis for the mice that would be bred to be at risk for RA. But the idea was it could be silent immune priming to increase the risk of inflammatory arthritis if something else occurs — maybe an infection, maybe a trauma, etc. So what they found was that in the mice, they didn't get inflammatory arthritis until they were primed for something else after, but the Th17 pathway was altered. They had very eloquent studies saying that if they blocked it, things would improve; if they upregulated it, it would worsen.

So why did I choose this? First of all, I think there's probably almost as high a number of microbiome studies of the differences in patients with RA versus healthy controls. I chose it because I do think patients ask you know what caused this — number one — but number two, more importantly, could we intervene earlier to try to make a healthy gut microbiome for our at-risk RA patients, and maybe they wouldn't develop RA, or for our RA patients in whom we're trying to treat to a target and they're not reaching it.

So hopefully more will come in this field of research. I think the presentation was very well done. Please follow us at RheumNow. Thank you.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×